Further thoughts to expand on what I expect or would like to see in tomorrows quarterly:
- Circa $600,000-$1Million in product revenue (another 200%+ increase QoQ possible?) - Circa $4Million+ in services revenue. This would be $1.5Million Hologic, $900K BARDA receipts, $250K Burnet Revenue, plus other existing deals ( circa $1.6Million) So a total of roughly $4.3Million? - Burnet update with revenues reflected in the services side - Update on Hologic payments and status of this deal - Update on the PHK study which has been going for some time in the US - Update on Febridx study (number of patients tested, and or number of bacterial patients tested) - Clarity on other services deals progressing and whether there is any updates
Time will tell. Wish they didnt wait until a Friday to release this but.
LDX Price at posting:
4.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)